| HONA |
Report |
Q2 revenue |
IN-LINE |
pred ~$4.68B vs. cons $4.67B |
MEDIUM |
| HONA |
Report |
Q2 organic sales growth |
IN-LINE |
pred ~5% vs. cons ~5% |
HIGH |
| HONA |
Report |
Q2 adjusted EPS |
IN-LINE |
pred ~$2.03 vs. cons $2.07 |
LOW |
| HONA |
Guide |
Inaugural FY26 adjusted EPS guide |
LOWER |
guide ~$8.10 vs. cons ~$8.35 (FY2026) |
MEDIUM |
| HONA |
Guide |
Inaugural FY26 revenue guide |
UNCHANGED |
guide ~$18.6B vs. cons ~$18.8B (FY2026) |
MEDIUM |
| HONA |
Guide |
Inaugural FY26 free cash flow guide |
LOWER |
guide ~$1.3B vs. cons ~$1.5B (FY2026) |
LOW |
| HONA |
Guide |
Backlog |
BETTER |
guide ~$19.5B vs. ~$19B prior (Q2 exit) |
MEDIUM |
| HONA |
Guide |
Standalone segment margin |
LOWER |
guide ~23.8% vs. cons ~24.5% (FY2026) |
LOW |
| HONA |
Return |
Day-1 residual (stock − beta × S&P 500) |
-3.0% |
— |
LOW |
| HONA |
Return |
5-day cumulative residual |
-5.0% (FOLLOW-THROUGH) |
The Q2 operating quarter is already known from HON's July 23 print (Aero +5% organic, margin compressed by ~$40M obsolescence, material supply still capping conversion, Defense flat), so the incremental catalyst is the first standalone P&L and inaugural guide. A conservative kitchen-sink first guide with full stranded-corporate/interest dis-synergies below the clean segment math pulls sell-side EPS/FCF estimates down; out-period revisions extend the initial negative move on a still-full ~23x valuation, driving follow-through lower. |
LOW |